Co-infection of COVID-19 and recurrent malaria
In tropical countries, endemic diseases such as malaria can be challenging to distinguish from COVID-19 because of the similarities in presenting symptoms. Here we reported a case of a young soldier with fever and myalgia six days before admission, with non-productive cough, chills, nausea and vomi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2021-05-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/13793 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850148832757678080 |
|---|---|
| author | Angelita Pusparani Joshua Henrina Alius Cahyadi |
| author_facet | Angelita Pusparani Joshua Henrina Alius Cahyadi |
| author_sort | Angelita Pusparani |
| collection | DOAJ |
| description |
In tropical countries, endemic diseases such as malaria can be challenging to distinguish from COVID-19 because of the similarities in presenting symptoms. Here we reported a case of a young soldier with fever and myalgia six days before admission, with non-productive cough, chills, nausea and vomiting, dizziness, and headache for two days. Previously, he had experienced four times of malaria infection. He had a history of positive non-falciparum malaria rapid diagnostic test (RDT) two days before admission. Significant findings were epigastric tenderness, splenomegaly, and severe thrombocytopenia of 36×103 cells / µL. A naso-oropharyngeal swab examination revealed a positive SARS-CoV-2 infection. Consequently, he was hospitalized for 12 days, successfully treated, and discharged without sequelae. Thus, in light of a pandemic, physicians need to raise the suspicion of concurrent COVID-19 infection with other tropical diseases, especially at-risk patients, because malaria and COVID-19 may share similar manifestations. Moreover, further ancillary testing, such as RDT, may be warranted.
|
| format | Article |
| id | doaj-art-e2e2d8f27bd44821b9bf30a509f70549 |
| institution | OA Journals |
| issn | 1972-2680 |
| language | English |
| publishDate | 2021-05-01 |
| publisher | The Journal of Infection in Developing Countries |
| record_format | Article |
| series | Journal of Infection in Developing Countries |
| spelling | doaj-art-e2e2d8f27bd44821b9bf30a509f705492025-08-20T02:27:07ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802021-05-01150510.3855/jidc.13793Co-infection of COVID-19 and recurrent malariaAngelita Pusparani0Joshua Henrina1Alius Cahyadi2Aloei Saboe General Hospital, Wongkaditi, Kota Utara, Kota Gorontalo, Gorontalo, IndonesiaSchool of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Penjaringan, Kota Jakarta Utara, Daerah Khusus Ibukota Jakarta, IndonesiaDepartment of Internal Medicine, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Penjaringan, Kota Jakarta Utara, Daerah Khusus Ibukota Jakarta, Indonesia In tropical countries, endemic diseases such as malaria can be challenging to distinguish from COVID-19 because of the similarities in presenting symptoms. Here we reported a case of a young soldier with fever and myalgia six days before admission, with non-productive cough, chills, nausea and vomiting, dizziness, and headache for two days. Previously, he had experienced four times of malaria infection. He had a history of positive non-falciparum malaria rapid diagnostic test (RDT) two days before admission. Significant findings were epigastric tenderness, splenomegaly, and severe thrombocytopenia of 36×103 cells / µL. A naso-oropharyngeal swab examination revealed a positive SARS-CoV-2 infection. Consequently, he was hospitalized for 12 days, successfully treated, and discharged without sequelae. Thus, in light of a pandemic, physicians need to raise the suspicion of concurrent COVID-19 infection with other tropical diseases, especially at-risk patients, because malaria and COVID-19 may share similar manifestations. Moreover, further ancillary testing, such as RDT, may be warranted. https://jidc.org/index.php/journal/article/view/13793COVID-19SARS-CoV-2MalariaCo-infection |
| spellingShingle | Angelita Pusparani Joshua Henrina Alius Cahyadi Co-infection of COVID-19 and recurrent malaria Journal of Infection in Developing Countries COVID-19 SARS-CoV-2 Malaria Co-infection |
| title | Co-infection of COVID-19 and recurrent malaria |
| title_full | Co-infection of COVID-19 and recurrent malaria |
| title_fullStr | Co-infection of COVID-19 and recurrent malaria |
| title_full_unstemmed | Co-infection of COVID-19 and recurrent malaria |
| title_short | Co-infection of COVID-19 and recurrent malaria |
| title_sort | co infection of covid 19 and recurrent malaria |
| topic | COVID-19 SARS-CoV-2 Malaria Co-infection |
| url | https://jidc.org/index.php/journal/article/view/13793 |
| work_keys_str_mv | AT angelitapusparani coinfectionofcovid19andrecurrentmalaria AT joshuahenrina coinfectionofcovid19andrecurrentmalaria AT aliuscahyadi coinfectionofcovid19andrecurrentmalaria |